|Bid||1.9000 x 900|
|Ask||2.2600 x 800|
|Day's range||1.8900 - 1.9800|
|52-week range||1.6000 - 7.0200|
|Beta (5Y monthly)||1.50|
|PE ratio (TTM)||N/A|
|Earnings date||22 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||31 Oct 2014|
|1y target est||18.50|
It's nice to see the Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) share price up 25% in a week. But that doesn't...
Participants on today's call are Evan Loh, M.D, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
We feel now is a pretty good time to analyse Paratek Pharmaceuticals, Inc.'s ( NASDAQ:PRTK ) business as it appears the...